Medscape News, Perspective & Articles

• Altimmune's Obesity Drug Safety Concerns Shrink Shares Altimmune Inc's experimental obesity drug helped reduce weight by over 10% on average in a mid-stage trial, the company said on Tuesday, but safety concerns sent its shares tumbling more than 50%.
  Reuters Health Information, March 21, 2023
• Episode 3: Pregnancy, Fertility, Ulcerative Colitis: Facts vs Fiction   Join Drs Sunanda Kane and Uma Mahadevan as they set out to separate fact from fiction when treating patients with ulcerative colitis before, during, and after pregnancy.
  Medscape, March 21, 2023
• Key Asthma Abstracts From AAAAI 2023   Key data from AAAAI 2023 highlight the impact of biologics on exacerbations, systemic corticosteroid use on healthcare resource utilization, patients starting dupilumab, and disparities in asthma treatment.
  Medscape, March 20, 2023
• ART Prescribing Patterns During Pregnancy for Women With HIV Are prescribing patterns for ART treatments during pregnancy in line with currently recommended guidelines?
  HIV Medicine, March 20, 2023
• AAD 2023 Dermatology Risks Are Likely Different for JAK Inhibitors Black box warnings for JAK inhibitors arise from rheumatoid arthritis studies, leading one expert to question the risk-benefit relevance to dermatologic diseases, particularly in younger patients.
  Medscape Medical News, March 18, 2023
• Migraine Treatment in Pregnancy A new survey provides insight into the practice patterns of women's healthcare providers as they treat pregnant women with migraine.
  Headache, March 13, 2023
• Few Patients Over 65 in Cancer Clinical Trials: Why? A recent analysis of 300 trials showed that patients in clinical trials were, on average, 6.5 years younger than the population for whom the drug was intended.
  MDedge News, March 10, 2023
• Mar 10 2023 This Week in Cardiology   ACC Recap Part 1: Sports, bempedoic acid NASCARs, tricuspid regurgitation, and more on revascularization of stable CAD. are the topics discussed by John Mandrola, MD, in this week's podcast.
  theheart.org on Medscape, March 10, 2023
• ECCO 2023 Nearly 1 in 3 Patients With IBD Affected by Skin Lesions No significant difference was found in skin lesion prevalence between patients with ulcerative colitis and Crohn's disease.
  Medscape Medical News, March 09, 2023
• DEA Controlled Substance Telehealth Proposals Draw Fire Two US Drug Enforcement Administration proposals on how telehealth can be used going forward to prescribe controlled substances are drawing criticism from mental health and addiction treatment specialists.
  Medscape Medical News, March 07, 2023
• Which Nonopioid Meds Are Best for Easing Acute Low Back Pain? A systematic review of 18 studies showed that muscle relaxants and NSAIDs reduced symptoms after 1 week.
  Medscape Medical News, March 01, 2023
• Alert FDA Declines Approval for Omecamtiv Mecarbil in HFrEF Citing a lack of efficacy data, the FDA has declined to approve omecamtiv mecarbil (Cytokinetics) for treatment of adults with chronic heart failure with reduced ejection fraction.
  News Alerts, March 01, 2023
• Beware Risk of Sedatives for Respiratory Patients ​​​​​​​ A letter in Lancet outlined the potential risk of sedative drugs for promoting asthma exacerbations.
  Medscape Medical News, February 27, 2023
• AAAAI 2023 Guidelines Urge Proactive De-Labeling of Penicillin Allergy New guidelines for de-labeling of penicillin allergy urge allergists to skip skin testing and recommend direct oral challenge to low-risk patients. Validated risk tools can help.
  Medscape Medical News, February 27, 2023
• Managing Isotretinoin's Bothersome Mucocutaneous Side Effects Emerging research suggests that there may be a role for oral omega-3 in reducing these side effects, which include cheilitis and dry skin.
  MDedge News, February 21, 2023
• Improving the Laboratory Evaluation of Monoclonal Gammopathies The authors developed a targeted clinical decision support alert to address oversights in ordering practices for the initial laboratory evaluation of monoclonal gammopathies.
  American Journal of Clinical Pathology, February 21, 2023
• FDA Panel Gives Unanimous Thumbs Up to OTC Naloxone Advisory committee members signalled unanimous approval for making naloxone nasal spray available over the counter so the drug can be more accessible to more people.
  Medscape Medical News, February 16, 2023
• Time for a National Ketamine Registry, Experts Say Efforts to create a registry to track ketamine treatment has long been stymied. Amid an increase in off-label use, unregulated clinics, and relaxed DEA rules, has the field finally reached a tipping point?
  Medscape Medical News, February 15, 2023
• Tips for Maximizing Colonoscopy Preps   Dr David Johnson shares some simple strategies for improving your patients' experience around the aspect of colonoscopy that they often dread the most.
  Medscape Gastroenterology, February 14, 2023
• Embattled iPLEDGE Program: Changes Ahead? The FDA announced that two FDA advisory committees will meet in March to discuss proposed changes to the embattled program to ''minimize burden on patients, pharmacies, and prescribers."
  Medscape Medical News, February 09, 2023